# OnCo record tailorx (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/tailorx/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "tailorx", "NCT00310180" ;
  schema:name "TAILORx"@en ;
  schema:description "Showed that most women with the commonest breast cancer can safely skip chemotherapy if a gene test says their risk is low or intermediate."@en ;
  schema:url <https://onco.cc/trials/tailorx/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00310180> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2006-04-07" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-early-high-risk/> ;
  onco:technologies <https://onco.cc/technologies/rna-seq/> ;
  onco:drugs <https://onco.cc/drugs/oncotype-dx/> ;
  onco:companies <https://onco.cc/companies/ecog-acrin/> ;
  onco:people <https://onco.cc/people/kathy-albain/>, <https://onco.cc/people/joseph-sparano/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-tailorx-nejm-2018/> .